{ "@context": "http:\/\/schema.org", "@type": "Article", "image": "https:\/\/sandiegouniontribune.sergipeconectado.com\/wp-content\/s\/2024\/08\/sut-l-q2-venture_NEL-017.jpg?w=150&strip=all", "headline": "Why is this biotech company selling its San Diego manufacturing facility?", "datePublished": "2024-08-01 16:57:07", "author": { "@type": "Person", "workLocation": { "@type": "Place" }, "Point": { "@type": "Point", "Type": "Journalist" }, "sameAs": [ "https:\/\/sandiegouniontribune.sergipeconectado.com\/author\/natallie-rochasduniontribune-com\/" ], "name": "Natallie Rocha" } } Skip to content

Why is this biotech company selling its San Diego manufacturing facility?

The sale is part of San Diego-based QuidelOrtho’s cost-saving strategy, which included a 7 percent global workforce reduction this year.

QuidelOrtho in Sorrento Valley on Tuesday, July 23, 2024 in San Diego, CA. (Nelvin C. Cepeda / The San Diego Union-Tribune)
(Nelvin C. Cepeda / The San Diego Union-Tribune)
QuidelOrtho in Sorrento Valley on Tuesday, July 23, 2024 in San Diego, CA. (Nelvin C. Cepeda / The San Diego Union-Tribune)
UPDATED:

It’s part of QuidelOrtho's cost-saving strategy, which included a 7 percent workforce reduction this year.

Subscribe to continue reading this article.

Already subscribed? To , click here.

Originally Published:

RevContent Feed

Events